Short interest for Acreage Holdings gives investors a sense of the degree to which investors are betting on the decline of Acreage Holdings's stock. Short interest data is updated every two weeks.

Acreage Holdings Stock (OTC:ACRHF), Short Interest Report

Acreage Holdings Inc is a vertically integrated, multi-state operator in the cannabis industry. Its business operations include cultivating, processing, distributing, and retailing cannabis. The Company derives its revenues from its retail dispensary business, where cannabis and cannabis-infused products are sold to consumers. Its geographic segments include New England, Mid-Atlantic, Midwest, West, and South. The Company operates under one operating segment, which is: the production and sale of cannabis products.

Cannabis Money,Stock,Photo,High,Quality

Cannabis

Earnings

News

ACRHF

CSE:ACRG

New York-Based Marijuana Company, Acreage, Sees YoY Revenue Decline, But Also Lower Net Loss

cannabis contract signing BZCCC (Iryna Rahalskaya on Shutterstock)(38)

TSX:WEED

WEED

Canopy Growth&#39;s shareholders gave a green light to the creation of a new class of exchangeable shares of the company during their special meeting held on Friday, April 12, as recommended earlier by Institutional Shareholder Services (ISS).At the meeting, shareholders passed a special resolution authorizing an amendment to the company&#39;s articles of incorporation, as amended, to create and authorize the issuance of an unlimited number of a new class of non-voting and non-participating exchangeable shares in the capital of Canopy Growth.A total of 32,250,578 common shares of Canopy, representing 35.40% of the issued and outstanding shares, were voted in connection with the meeting by the company&#39;s shareholders and proxyholders.he move enables the acceleration of Canopy Growth&#39;s entry into the U.S. THC market, which is forecasted to hit roughly $50 billion in 2026, the company said on Monday in a press release.

Canopy Is &#39;Cautiously Optimistic&#39; On Cannabis Rescheduling Following Major Step Toward Entry Into US THC Market

nyhochul

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

New York Gov Hochul Orders Review Of Cannabis Licensing Process After Numerous Setbacks

ACREAGE HLDG CL E SUB VTG by Acreage Holdings Inc.

Acreage Holdings Inc

The Company&#39;s annual&nbsp;guidance&nbsp;remains unchanged with expectations for 2024 revenues in a range of&nbsp;$2.5 billion&nbsp;to&nbsp;$2.7 billion&nbsp;and Adjusted EBITDAR in a range of&nbsp;$655 million&nbsp;to&nbsp;$695 million.&nbsp;
The full year&nbsp;guidance&nbsp;includes the impact of the Tropicana Las Vegas closure and contemplates the continued ramp of the Chicago Temporary Casino, coupled with growth in the Company&#39;s International Interactive business, and the revenue ramp from the introduction of iGaming operations in Rhode Island.

Guidance

BALY

Bally's Says 2024 Guidance Remains Unchanged With Expectations For Revenues Of $2.5B-$2.7B, Est $2.581B

Titan Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.45 by 35.56 percent. This is a 45.28 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $482.209 million which missed the analyst consensus estimate of $537.321 million by 10.26 percent. This is a 12.11 percent decrease over sales of $548.644 million the same period last year.

Earnings Misses

Titan Intl Q1 2024 Adj EPS $0.29 Misses $0.45 Estimate, Sales $482.209M Miss $537.321M Estimate

Radian Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDN#NYSE">RDN</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.84 by 22.62 percent. This is a 5.1 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $235.857 million which missed the analyst consensus estimate of $236.627 million by 0.33 percent. This is a 1.12 percent increase over sales of $233.238 million the same period last year.

Earnings Beats

Radian Group Q1 2024 Adj EPS $1.03 Beats $0.84 Estimate, Sales $235.857M Miss $236.627M Estimate

NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>), ("NuCana" or the "Company"), announced that it has received a written notification (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market, LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement") and the matter is closed. &nbsp;
As announced on May 12, 2023, the Company was notified by Nasdaq that it was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American Depositary Shares (the "ADSs") had been below $1.00 for 30 consecutive business days. On November 13, 2023, in connection with the transfer of its ADSs to the Nasdaq Capital Market, Nasdaq granted the Company an additional 180-day period (or until May 6, 2024) to regain compliance with the Minimum Bid Price Requirement by maintaining a minimum closing bid price of $1.00 or more for at least 10 consecutive business days.
The Notification Letter confirmed that the Company evidenced a closing bid price of the Company's ADSs on Nasdaq at or greater than the $1.00 per ADS minimum requirement for 10 consecutive business days from April 16, 2024 to April 29, 2024 and that the Company has regained compliance with the Minimum Bid Price Requirement.

NCNA

NuCana Regains Compliance With Nasdaq Minimum Bid Price Requirement

Ryman Hospitality Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHP#NYSE">RHP</a>) reported quarterly earnings of $1.60 per share which missed the analyst consensus estimate of $1.64 by 2.44 percent. The company reported quarterly sales of $528.345 million which missed the analyst consensus estimate of $530.855 million by 0.47 percent. This is a 7.45 percent increase over sales of $491.719 million the same period last year.

Ryman Hospitality Props Q1 2024 FFO $1.60 Misses $1.64 Estimate, Sales $528.345M Miss $530.855M Estimate

At the recent <a href="https://www.benzinga.com/topic/cannabis-capital-conference">Benzinga Cannabis Capital Conference</a> in Florida, a panel featuring industry experts David Mukpo, CEO of Pamos Beverage, Rachel Burkons from the Cannabis Hospitality Coalition, Diana Eberlein, president of Cannabis Beverage and Jonathan Black of Cheech &amp; Chong. The panel was moderated by Ricardo Baca from Grasslands, discussed the perspectives of <a href="https://www.benzinga.com/markets/cannabis/24/04/38528176/thc-beverage-sector-is-probably-bigger-than-we-realize-say-industry-experts-and-its-not-too-late">cannabis beverages</a>. The encounter, entitled &#8220;High Spirits: Reshaping Social Consumption In The Hospitality Space,&#8221; highlighted a segment poised for explosive growth in a post-280E tax environment.
<h3 class="wp-block-heading">Beverages And Mass Consumption</h3>
The discussion opened with a key question about the most exciting developments in social cannabis consumption, to which the unanimous response was &#8220;Beverages.&#8221; 
The strategic push to incorporate these products into arenas, restaurants and bars was a major theme. Rachel Bachman highlighted the seamless integration possible due to the existing familiarity with beverages in hospitality. "And because we&#8217;re working with people who understand beverage and hospitality in that bar restaurant channel, we don&#8217;t need to reinvent the wheel." 
Diana Eberlein shared striking insights into the market performance of<a href="https://www.benzinga.com/topic/cannabis-beverages"> THC beverages</a>, which are beginning to outsell traditional staples across various retail settings. "We are hearing reports from other retailers saying that THC beverages are outselling any single varietals of wine, outselling vodka. Those are big numbers," Eberlein pointed out. This trend underscores the potential for hemp beverages to bolster bar sales as alcohol consumption declines.
<h3 class="wp-block-heading">High-Quality Lounges</h3>
While the mass consumption market is thriving, the path to establishing high-quality <a href="https://www.benzinga.com/markets/cannabis/23/06/33062937/exclusive-cannabis-lounges-are-redefining-hospitality-cirrus-social-club-founder-says">cannabis lounges</a> is fraught with regulatory challenges. Rachel Bachman looked at some of the operational hurdles. "There have been a lot of ways operators have had one hand, both hands tied behind their back."
However, she also sees significant opportunities, especially as regulations evolve and expand across states. "So creating low dose beverages at the 2.5 level for hospitality where folks can maybe order 2 or 3 depending on their dose, is a really great way for operators to also make some margin on this category," she added.
Pro tip: Learn all about the future of the cannabis industry at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players and policymakers. Get your tickets now by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>, and access a 20% discount using the code JAVI20.
Positively valuing cannabis-lounges David Mukpo also emphasized the importance of integrating low-dose THC beverages into conventional social settings. &#8220;I think certainly from a regulated space, seeing high-quality lounges that are sustainable, launching in the regulated space is fantastic. And I think it&#8217;s going to be a critical piece of the industry moving forward.&#8221; He noted the shift towards beverages typically reserved for alcohol, spotlighting the growing consumer adoption.
<h3 class="wp-block-heading">Beverages Will Fuel Cannabis Hospitality</h3>
Jonathan Black echoed the sentiment about the importance of adjustable dosing to meet individual needs, adding that the lack of a standard dose as both a challenge and an opportunity. "There is no standard dose. On my team, let alone in the country…the first answer is everyone has a different dose, and we need to give everybody access to that dose."
The panelists agreed that education would play a crucial role in this transition. <a href="https://www.benzinga.com/markets/cannabis/24/03/37569338/22-most-influential-women-in-the-cannabis-industry-and-the-secret-to-meet-them-in-person-in-2024">Diana Eberlein</a> stressed the importance of educating distributors and retailers about THC dosages and product offerings. "I mean, especially with the increased accessibility of these products being in total wine and in front of a consumer that might not understand dosages of THC, even understand how THC will impact their body. Education is crucial," she said.

Events

Exclusives

Markets

Are Hemp-THC Beverages Competing With Alcohol? Experts Discuss New Alternatives For Adult Beverages At Benzinga Cannabis Conference

Metagenomi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced it has regained full global rights to research, develop, manufacture, and commercialize its wholly-owned gene editing technologies, including base editors and RNA-mediated integration systems (RIGS), which were previously subject to exclusive rights granted to Moderna, Inc. Metagenomi and Moderna have mutually agreed to terminate their collaboration on primary hyperoxaluria type 1 (PH1), and rights to develop the PH1 program, as well as all other rights granted under the collaboration, will be returned as part of the termination. &nbsp;
"We are pleased to regain full control of the development of base editing technology and RIGS systems so that we may advance them in areas of significant need, such as Alpha-1 antitrypsin deficiency and Wilson's disease,"&nbsp;said Brian C. Thomas, Ph.D., Chief Executive Officer &amp; Founder, Metagenomi, Inc.
Moderna's involvement in the collaboration, which includes the PH1 program, ended in conjunction with a strategic prioritization by the company. Moderna remains a Metagenomi shareholder.
This announcement represents a renewed opportunity to advance curative genetic medicine through the translation of Metagenomi's broad toolbox of wholly-owned gene editing technologies, as well as a broadened ability to engage with partners in target-specific application of these technologies.&nbsp;
"Over the past several years, we have built internal capabilities and expertise required to advance programs to the next phase of development," said Dr. Thomas. "In addition to exponential growth in terms of talent and footprint, we have leveraged significant private and public funding to greatly expand our gene editing toolbox, and established in-house manufacturing. With this announcement, we continue to have the opportunity to accelerate our mission to become the premier gene editing company."

Metagenomi To Regain Full Development Rights To Its Wholly-Owned Base Editing And Rigs Systems

OPENLANE Sees FY24 Adj. EPS $0.77-$0.87 Vs $0.83 Est.

Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) reported financial results for the first quarter Wednesday after the bell. Here&#8217;s a look at the <a href="https://www.benzinga.com/pressreleases/24/05/b38564402/carvana-announces-record-first-quarter-2024-results">key metrics from the quarter</a>. 
Q1 Earnings: Carvana reported first-quarter revenue of $3.061 billion, which beat the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $2.673 billion, according to&nbsp;<a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company reported adjusted EBITDA of $235 million.
Carvana sold 91,878 vehicles in the fourth quarter, up 16% on a year-over-year basis.
&#8220;In the&nbsp;first quarter, we delivered our best results in company history, validating our long-held belief that Carvana&#8217;s online retail model can drive industry-leading profitability while delivering industry-leading customer experiences. We reached new&nbsp;Q1&nbsp;milestones for all key profitability metrics while also growing&nbsp;16%&nbsp;year over year,&#8221; said Ernie Garcia, founder and CEO of Carvana.
&#8220;With these strong results, significant fundamental margin opportunities ahead, and a nationwide infrastructure that can support multiples of our current scale, we have never been more confident in our opportunity to become the largest and most profitable automotive retailer and to buy and sell millions of cars.&#8221;
Outlook:&nbsp;Carvana anticipates a sequential increase in its year-over-year growth rate in retail units in the second quarter. The company also expects a sequential increase in adjusted EBITDA.
Carvana also noted it now expects to &#8220;comfortably deliver&#8221; on its outlook of year-over-year growth in retail units sold and adjusted EBITDA for full-year 2024.
Management will hold a conference call to discuss these results at 5:30 p.m. ET.
CVNA Price Action: <a href="https://www.benzinga.com/quote/CVNA" target="_blank" rel="noreferrer noopener">Carvana shares</a> were up 34.34.% after hours at $117 at the time of publication Wednesday, according to <a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38453221/another-blow-to-tesla-hertzs-ev-disposal-plan-jumps-by-10k-as-car-rental-company-aims-for-95-gas-pow">Another Blow To Tesla? Hertz&#8217;s EV Disposal Plan Jumps By 10K As Car-Rental Company Aims For 95% Gas-Powered Fleet By Year-End</a>
Photo: Shutterstock.

Movers

CVNA

Carvana Stock Jumps On Q1 Earnings: Revenue Beat, Vehicles Sold Up 16%, Strong Guidance And More

PAYC

Paycom To Expand Its Product Offerings And Geographic Reach Into Ireland

Tiptree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIPT#NASDAQ">TIPT</a>) reported quarterly earnings of $0.22 per share. This is a 833.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported $498.22 million in sales this quarter. This is a 30.55 percent increase over sales of $381.63 million the same period last year.

TIPT

Tiptree Q1 EPS $0.22 Up From $(0.03) YoY, Sales $498.22M Up From $381.63M YoY

LUNG

Pulmonx Sees FY24 Revenue $81M-$84M Vs $82.189M Est.

The Company continues to expect its capital program to be heavily weighted to the first half of the year, with production expected to increase from&nbsp;first quarter&nbsp;levels.&nbsp;&nbsp;

Marathon Oil Says Originally Provided 2024 Production, Capital Expenditure, Cost, And Tax Guidance Ranges Are All Unchanged

ENVX

Enovix Sees Q2 2024 Adj. EPS $(0.28)-$(0.22) Vs $(0.22) Est.; Revenue $3.0M-$4.0M Vs $4.054M Est.

Broadstone Net Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNL#NYSE">BNL</a>) reported quarterly earnings of $0.36 per share which met the analyst consensus estimate. This is a 5.88 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $105.366 million which missed the analyst consensus estimate of $107.054 million by 1.58 percent. This is a 11.45 percent decrease over sales of $118.992 million the same period last year.

Broadstone Net Lease Q1 2024 FFO $0.36, Inline, Sales $105.366M Miss $107.054M Estimate

UPWK

Upwork Sees Q2 Adj. EPS $0.21-$0.23 vs $0.20 Est., Revenue $190M-$195M vs $192.04M Est.

Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) reported quarterly earnings of $2.57 per share which beat the analyst consensus estimate of $2.40 by 7.08 percent. This is a 10.3 percent increase over earnings of $2.33 per share from the same period last year. The company reported quarterly sales of $1.425 billion which missed the analyst consensus estimate of $1.600 billion by 10.94 percent. This is a 6.00 percent increase over sales of $1.344 billion the same period last year.

Axis Capital Holdings Q1 2024 Adj EPS $2.57 Beats $2.40 Estimate, Sales $1.425B Miss $1.600B Estimate

Upwork (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.08 by 62.5 percent. The company reported quarterly sales of $190.900 million which beat the analyst consensus estimate of $185.873 million by 2.70 percent. This is a 18.68 percent increase over sales of $160.858 million the same period last year.

Upwork Q1 2024 GAAP EPS $0.13 Beats $0.08 Estimate, Sales $190.900M Beat $185.873M Estimate

Knowles Sees Q2 2024 Adj. EPS $0.22-$0.26 Vs $0.23 Est.; Revenue $199M-$209M Vs $205.5M Est.

Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is a 39.39 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $65.250 million which beat the analyst consensus estimate of $63.344 million by 3.01 percent. This is a 15.48 percent decrease over sales of $77.199 million the same period last year.

HDSN

Hudson Technologies Q1 2024 GAAP EPS $0.20, Inline, Sales $65.250M Beat $63.344M Estimate

Cannabis measure to enter Florida ballot after court ruling

Trulieve-led Florida adult-use cannabis campaign gathers steam

New York judge strikes down state's marijuana marketing laws

Cannabis rally sparks concerns amid moves to mainstream

FDA chief sees no reason for delay in cannabis rescheduling

White House says marijuana rescheduling review is now with DOJ

Cannabis stocks outperform as pressure mount on DEA to reschedule marijuana

Cannabis stocks outperform as pressure mounts on DEA to reschedule marijuana

Acreage Holdings reports Q4 results

Marijuana rescheduling decision is imminent, anti-cannabis group says

ACRDF

AYRWF

CLVR

CNBS

CRLBF

CRON

FLGC

LFLY

MSOS

SNDL

TCNNF

TLRY

TSNDF

VRNOF

YOLO

Press Releases

Acreage Reports Second Quarter 2023 Financial Results

General

Acreage Introduces Craft Cannabis Brand Superflux to New Jersey

Acreage Reports Third Quarter 2023 Financial Results

Acreage Deepens New Jersey Operations with Completion of Egg Harbor Facility Expansion

Management

Acreage Announces Executive Leadership Transition

Acreage Launches The Botanist Gummies in New York and Provides Core Market Update